According to the most predominant hypothesis, Parkinsonism, the main symptoms of which are tremor, muscle rigidity and akinesia, seems to result from disturbances in the basal ganglia, especially disturbance of the amine balance between the cholinergic and dopaminergic system in the corpus striatum (1, 2). i.-Dopa (r,-dihydroxyphell ylalanine) has recently been used, as well as anticholinergic agents, antihistamines and phenothiazines, in the treatment of Parkinsonism. Although it is remarkably effective against muscle rigidity and akinesia, L-dopa shows only slight inhibition against tremor both in animal experiments and clinical cases (3). Some authors ascribe Parkinsonism to a decrease in intracerebral 5-HT (5-hydroxytryptamine) level (4) and there are reports about the ap plication of 5-HTP (5-hydroxytryptophan), a metabolic precursor of 5-HT, to the treat ment of Parkinsonisni (5, 6).
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Tremorine-induced tremor, first described by G.M. Everett (7) , is most frequently used to elucidate the mechanism of tremor and in the primary screening of anti-Parkinsonism.
R. Rodoriguez observed that DL-5HTP slightly inhibited tremorine-induced tremor in mice (8). Goldstein et al. have indicated that upon tremor in monkeys with mesencephalic lesions, inhibitory effect was observed with high doses of DL-5HTP and that atropine was intensified by DL-5HTP, the dose of the latter being such as to cause no tremor-inhibition (9, 10) .
To determine further the role of 5-HT in extrapyramidal dysfunction, the effect of L.-5HTP, on tremorine and oxotremorine-induced tremor was investigated herein.
Male adult dds mice weighing 19 to 21 g and male adult Wister rats weighing 180 to 220 g were used and divided into groups of 10. Graded doses of test drugs were given orally, and 15 min later, mice were given 25 mg of tremorine s.c. and rats 50 ,ug of oxo tremorine s.c. each per kg of body wt. The animals were then placed in individual cages of plastic and visually observed for the occurrence of tremor for one min 15 and 30 min after trernorine or oxotrernorine. Such observation was based on "all or none type" and ED,, for tremor inhibition estimated by the method of Litchfield and Wilcoxon (11). For drug interaction studies, graded doses of test drugs were simultaneously administered with a fixed amount of L-5HTP, provided however that p-chlorophenylalanine (P-CPA) had been administered i.p. 72 hr before the day of experiment. Atropine sulfate, scopolamine hydrobromide, benztropine methanesulfonate, tri hexyphenidyl hydrochloride, L-5HTP, P-CPA, tremorine hydrochloride and oxotremorine were dissolved in distilled water or suspended in 0.3% w/v carboxyl methylcellulose solu tion just before administration. All dosages refer to the weight of the salt and all the drugs were injected in a volume of 1 ml per 100 g of body wt.
Administration of tremorine and oxotremorine caused marked tremor of the head and limbs. Maximal effects were observed 30 min after tremorine and 15 min after oxo tremorine. When 200 to 1500 mg/kg of L-5HTP given to mice and 50 to 400 mg/kg to rats, tremor inhibition was not noted. Behavioral effects were propotional to the doses of L-5HTP, and symptoms included body shaking, lacrimation, salivation and diarrhea in both species. Anticholinergic agents, atropine, scopolamine, benztropine and trihexyphenidyl showed a remarkable inhibitory effect upon tremorine-induced tremor in mice. When these anti cholinergic agents were accompanied by 200 mg/kg of L-5HTP, the ED,, decreased to about half that of the anticholinergic agents alone (Table 1) .
This was also the case with oxotremorine-induced tremor in rats, 100 mg/kg of L 5HTP increasing remarkably the anti-tremor effect of anticholinergic agents (Table 1) . In rats previously treated with P-CPA (316 mg/kg, i.p.) which is a specific inhibitor of trypto phan-hydroxylase (12), anti-tremor effect of atropine and scopolamine decreased and the ED,,, could not be estimated (Table 2) .
We also determined the 50% tremulous dose of oxotremorine in normal rats and P-CPA pretreated rats. The TD,, of oxotremorine in normal rats and P-CPA pretreated rats was 24. in normal rats and p-CPA pre treated rats * Graded doses of test drugs were given orally 15 min before the injection of oxotremorine (50pg/kg, s.c.). ** p-CPA (316 mg/kg , i.p.) was administered 72 hr before the beginning of an experiment. *** Numerator indicates the number of rats inhibiting tremor and the deno minator the number of rats.
